Melatonin attenuates methotrexate-induced oxidative stress and renal damage in rats

Cell Biochemistry and Function

Volumn 28, Issue 5, 2010, Pages 426-433

  Abraham, Premila ^a   Kolli, Viswa Kalyan ^a   Rabi, Suganthy ^b  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b Department of Anatomy ^*  (India)

Author keywords

Melatonin; Methotrexate; Nephrotoxicity; Oxidative stress; Rats

Indexed keywords

ANTIOXIDANT; CREATININE; ENZYME; MELATONIN; METHOTREXATE; MYELOPEROXIDASE; ANTINEOPLASTIC ANTIMETABOLITE; MALONALDEHYDE; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; ENZYME ACTIVITY; HISTOLOGY; KIDNEY HOMOGENATE; KIDNEY INJURY; MALE; MICROSCOPY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; ANIMAL; BLOOD; DRUG EFFECTS; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; METABOLISM; TOXICITY; WISTAR RAT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTIOXIDANTS; CREATININE; INJECTIONS, INTRAPERITONEAL; KIDNEY; MALE; MALONDIALDEHYDE; MELATONIN; METHOTREXATE; OXIDATIVE STRESS; PEROXIDASE; RATS; RATS, WISTAR;

RATTUS;

EID: 77956865325     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1676     Document Type: Article

References (57)

1. Djerassi I. High-dose methotrexate (NSC-740) and citrovorum factor (NSC-3590) rescue: background and rationale. Cancer Chemother Rep 1975; 6: 3-6.
2. Ackland SP, Schilsky RL. High-dose methotrexate: A critical reappraisal. J Clin Oncol 1987; 5: 2017-2031.
3. Frei RD, Blum RH, Pitman SW. High dose methotrexate with leucovorin rescue: Rationale and spectrum of antitumor activity. Am J Med 1980; 68: 370-376.
4. Jolivet J, Cowan KH, Curt GA. The pharmacology and clinical use of methotrexate. N Engl J Med 1983; 309: 1094-1104.
5. Doan T, Massarotti E. Rheumatoid arthritis, an overview of new and emerging therapies. J Clin Pharmacol 2005; 45: 751-762.
6. Helen STE, Schiano TD, Kuan SF. Hepatic effects of long term methotrexate use in the treatment of inflammatory bowel disease. Am J Gastroenterol 2000; 5: 3150-3156.
7. Izzedine H, Launay-Vacher V, Karie S. Is low-dose methotrexate nephrotoxic? Case report and review of the literature. Clin Nephrol 2005; 64: 315-319. (Pubitemid 41448436)
8. Abelson HT, Fosburg MT, Beardsley GP. Methotrexate-induced renal impairment: Clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. J Clin Oncol 1983; 1: 208-216.
9. Ahmed S, Shen FH, BleyerWA. Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis. Arch Intern Med 1978; 138: 1146-1147.
10. Seideman P, Muller-Suur R, Ekman E. Renal effects of low dose methotrexate in rheumatoid arthritis. J Rheumatol 1993; 20: 1126-1128. (Pubitemid 23278161)
11. Jacobs SA, Stoller RG, Chabner BA. 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate. J Clin Invest 1976; 57: 534-538.
12. Lankelma J, Van Der Klein E, Ramaekers F. The role of 7-hydroxymethotrexate during methotrexate anti-cancer therapy. Cancer Lett 1980; 9: 133-142.
13. Messmann R, Allegra C. Antifolates. In Chabner B, Longo D (eds). Cancer chemotherapy and Biotherapy. LippincottWilliams & Wilkins: Philadelphia, 2001; 139-184.
14. Devrim E, Cetin R, Kilicoglu B. Methotrexate causes oxidative stress in rat kidney tissues. Ren Fail 2005; 27: 771-773.
15. Oktem F, Yilmaz HR, Ozguner F, et al. Methotrexate-induced renal oxidative stress in rats : The role of a novel antioxidant caffeic acid phenethyl ester. Toxicol Ind Health 2006; 22: 241-247.
16. Jahovic N, Cevik H, Sehirli AO. Melatonin prevents methotrexate induced hepatorenal oxidative injury in rats. J Pineal Res 2003; 34: 282-287.
17. Kolli VK, Abraham P, Isaac B. Neutrophil infiltration and oxidative stress may play a critical role in methotrexate-induced renal damage. Chemotherapy 2009; 55: 83-90.
18. Lenaz G. Role of mitochondria in oxidative stress and ageing. Biochim Biophys Acta 1998; 1366: 53-56.
19. Ortiz GG, Reiter RJ, Zuniga G. Genotoxicity of paraquat: Micronuclei induced in bone marrow and peripheral blood are inhibited by melatonin. Mutat Res 2000; 464: 239-245.
20. Xu J, Sun S, Wei W. Melatonin reduces mortality and oxidatively mediated hepatic and renal damage due to diquat treatment. J Pineal Res 2007; 42: 166-171.
21. Zhang L,WeiW, Xu J. Inhibitory effect of melatonin on diquat-induced lipid peroxidation in vivo as assessed by the measurement of F2- isoprostanes. J Pineal Res 2006; 40: 326-331.
22. Ucar M, Korkmaz A, Reiter RJ. Melatonin alleviates lung damage induced by the chemical warfare agent nitrogen mustard. Toxicol Lett 2007; 173: 124-131.
23. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
24. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968; 25: 192-205.
25. Ohkuma N, Matsuo S, Tutsui M, Ohkawara A. Superoxide dismutase in the epidermisQ4 (author's transl). Nippon Hifuka Gakkai Zasshi 1982; 92: 583-590.
26. Aebi IH. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
27. Awasthi YC, Dao DD, Saneto RP. Interrelationship between anionic and cationic forms of glutathione S-transferases of human liver. Biochem J 1980; 191: 1-10.
28. Racker E. Glutathione reductase from bakers' yeast and beef liver. J Biol Chem 1955; 217: 855-865.
29. Nakamura W, Hosada S. Purification and properties of rat liver glutathione peroxidase. Biochim Biophys Acta 1974; 358: 251-260.
30. Diaz-Granados N, Howe K, Lu J, McKay DM. Dextransulfate sodiuminduced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity. Am J Pathol 2000; 156: 2169-2177.
31. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
32. Grönroos M, Chen M, Jahnukainen T, Capitanio A, Aizman RI, Celsi G. Methotrexate induces cell swelling and necrosis in renal tubular cells. Pediatr Blood Cancer. 2006; 46: 624-629.
33. Izzedine H, Launay-Vacher V, Karie S, Caramella C, de Person F, Deray G. Is low-dose methotrexate nephrotoxic? Case report and review of the literature. Clin Nephrol 2005; 64: 315-319. (Pubitemid 41448436)
34. Xu J, Sun S, Wei W. Melatonin reduces mortality and oxidatively mediated hepatic and renal damage due to diquat treatment. J Pineal Res 2007; 42: 166-171.
35. Ogeturk M, Kui I, Kavakli A. Reduction of carbon tetrachlorideinduced nephropathy by melatonin administration. Cell Biochem Funct 2005; 23: 85-92.
36. Reiter RJ, Pablos MI, Agapito TT. Melatonin in the context of free radical theory of aging. Ann NY Acad Sci 1996; 786: 362-378.
37. Reiter RJ, Melchiorri D, Sewerynek E. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995; 18: 1-11.
38. Reiter RJ. Oxidative damage in the central nervous system: Protection by melatonin. Prog Neurobiol 1998; 56: 359-384.
39. Farooqui AA, Horrocks LA. Lipid peroxides in the free radical pathophysiology of brain diseases. Cell Mol Neurobiol 1998; 18: 599-608.
40. Swiderska-kolacz G, Klusek A. The effect of melatonin on glutathione and glutathione transferase and glutathione peroxidase activities in the mouse liver and kidney in vivo. Neuro Endocrinol Lett 2006; 27: 365-368.
41. Tomas-Zapico C, Coto-Montes A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 2005; 39: 99-104.
42. Sener G, Tugtepe H, Velioglu-Ogunc A. Melatonin prevents neutrophil mediated oxidative injury in Escherichia Coli induced pyelonephritis in rats. J Pineal Res 2006; 41: 220-227.
43. Kolli VK, Abraham P, Isaac B. Alteration in antioxidant defense mechanisms in the small intestines of methotrexate treated rat may contribute to its gastrointestinal toxicity. Cancer Therapy 2008; 6: 17-26.
44. Reiter RJ, Tan DX, Maldonado MD. Melatonin as an antioxidant: Physiology versus pharmacology. J Pineal Res 2005; 39: 215-220.
45. Kolli VK, Abraham P, Isaac B. Neutrophil Infiltration and Oxidative Stress May Play a Critical Role in Methotrexate-Induced Renal Damage. Chemotherapy 2009; 55: 83-90.
46. Rodriguez C. Regulation of antioxidant enzymes: A significant role for melatonin. J Pineal Res 2004; 36: 1-9.
47. Galijasevic S, Abdulhamide I, Abu-Soud HM. Melatonin is a potent inhibitor myeloperoxidase. Biochemistry 2008; 47: 2668-2677.
48. Kureer Z, Oguz E, Iraz M. Melatonin improves methanol intoxication - induced oxidative liver injury in rats. J Pineal Res 2007; 43: 42-49.
49. Pan L, Xu W, Fu JH. Effect of melatonin on hypoxia-induced oxidant/antioxidant imbalance in the lung of neonatal rats with chronic lung disease. Zhongguo Dang Dai Er Ke Za Zhi 2009; 11: 581-584.
50. Sener G, Sehirli O, Yegen BC, Cetinel S, Gedik N, Sakarcan A. Melatonin attenuates ifosfamide-induced Fanconi syndrome in rats. J Pineal Res. 2004; 37: 17-25.
51. Reiter RJ, Paredes SD, Manchester LC, Tan DX. Reducing oxidative/ nitrosative stress: A newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol. 2009; 44: 175-200.
52. Kalpakcioglu B, Senel K. The role of melatonin in rheumatic diseases. Infect Disord Drug Targets 2009; 9: 453-456.
53. Kedziora-Kornatowska K, Szewczyk-Golec K, Kozakiewicz M. Antioxidative effects of melatonin administration in elderly primary essential hypertension patients. J Pineal Res 2008; 45: 312-317.
54. Tamura H, Takasaki A, Miwa I. et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res 2008; 44: 280-287.
55. Seabra ML, Bignotto M, Pinto LR Jr. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res 2000; 29: 193-200.
56. Jahnke G, Marr M, Myers C. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague- Dawley rats. Toxicol Sci 1999; 50: 271-279.
57. Reiter R, Gultekin F, Flores LJ. Melatonin: Potential utility for improving public health. TAF Prev Med Bull 2006; 5: 131-158.